381 related articles for article (PubMed ID: 29800779)
1. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Haroon E; Daguanno AW; Woolwine BJ; Goldsmith DR; Baer WM; Wommack EC; Felger JC; Miller AH
Psychoneuroendocrinology; 2018 Sep; 95():43-49. PubMed ID: 29800779
[TBL] [Abstract][Full Text] [Related]
2. Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression.
Bekhbat M; Chu K; Le NA; Woolwine BJ; Haroon E; Miller AH; Felger JC
Psychoneuroendocrinology; 2018 Dec; 98():222-229. PubMed ID: 30249443
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
Yang C; Bosker FJ; Li J; Schoevers RA
BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression.
Fitzgerald P; O'Brien SM; Scully P; Rijkers K; Scott LV; Dinan TG
Psychol Med; 2006 Jan; 36(1):37-43. PubMed ID: 16255837
[TBL] [Abstract][Full Text] [Related]
5. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
[TBL] [Abstract][Full Text] [Related]
6. Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
Fernandes BM; Scotti-Muzzi E; Soeiro-de-Souza MG
Eur J Clin Pharmacol; 2022 Mar; 78(3):339-349. PubMed ID: 34708271
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, inflammation and treatment response in major depression.
Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Raison CL; Rutherford RE; Woolwine BJ; Shuo C; Schettler P; Drake DF; Haroon E; Miller AH
JAMA Psychiatry; 2013 Jan; 70(1):31-41. PubMed ID: 22945416
[TBL] [Abstract][Full Text] [Related]
9. Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder.
Yamasaki K; Hasegawa T; Takeda M
Neuropsychopharmacol Rep; 2020 Jun; 40(2):130-137. PubMed ID: 32162496
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study.
Kappelmann N; Czamara D; Rost N; Moser S; Schmoll V; Trastulla L; Stochl J; Lucae S; ; Binder EB; Khandaker GM; Arloth J
Brain Behav Immun; 2021 Jul; 95():256-268. PubMed ID: 33794315
[TBL] [Abstract][Full Text] [Related]
11. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.
Vogelzangs N; Duivis HE; Beekman AT; Kluft C; Neuteboom J; Hoogendijk W; Smit JH; de Jonge P; Penninx BW
Transl Psychiatry; 2012 Feb; 2(2):e79. PubMed ID: 22832816
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review.
Yang C; Wardenaar KJ; Bosker FJ; Li J; Schoevers RA
J Affect Disord; 2019 Oct; 257():640-649. PubMed ID: 31357161
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial.
Brunoni AR; Machado-Vieira R; Sampaio-Junior B; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Carvalho AF; Cho HJ; Gattaz WF; Teixeira AL
J Affect Disord; 2015 Oct; 185():209-13. PubMed ID: 26241865
[TBL] [Abstract][Full Text] [Related]
15. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
[TBL] [Abstract][Full Text] [Related]
16. Connection between inflammatory markers, antidepressants and depression.
Crnković D; Buljan D; Karlović D; Krmek M
Acta Clin Croat; 2012 Mar; 51(1):25-33. PubMed ID: 22919999
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of infliximab in treatment-resistant depression: A systematic review and meta-analysis.
Bavaresco DV; Uggioni MLR; Ferraz SD; Marques RMM; Simon CS; Dagostin VS; Grande AJ; da Rosa MI
Pharmacol Biochem Behav; 2020 Jan; 188():172838. PubMed ID: 31837338
[TBL] [Abstract][Full Text] [Related]
18. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Hannestad J; DellaGioia N; Bloch M
Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103
[TBL] [Abstract][Full Text] [Related]
19. Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis.
Więdłocha M; Marcinowicz P; Krupa R; Janoska-Jaździk M; Janus M; Dębowska W; Mosiołek A; Waszkiewicz N; Szulc A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):217-226. PubMed ID: 28445690
[TBL] [Abstract][Full Text] [Related]
20. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
